AKT1 and Miyoshi myopathy: Based on our findings, we can surmise that the progression of MGUS to MM is driven by aberrant cytokine secretion, which leads to inflammation immune dysfunction, and dysregulation of the PI3K/AKT/mTOR signaling pathway.